Eisai
4523.T
#2204
Rank
A$12.67 B
Marketcap
A$44.94
Share price
1.56%
Change (1 day)
2.85%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.30. an increase over its 2024 EPS that were of A$1.47.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.6411.85%
2024A$1.47-32.63%
2023A$2.185.52%
2022A$2.07-74.01%
2021A$7.95-66.58%
2020A$23.7998.24%
2019A$12.0017.01%
2018A$10.2537.78%
2017A$7.44-27.62%
2016A$10.2835.33%
2015A$7.60-2.82%
2014A$7.82-27.66%
2013A$10.81-27.49%
2012A$14.91-12.67%
2011A$17.0788.08%
2010A$9.08-11.06%
2009A$10.21-390.15%
2008A-$3.52-127.78%
2007A$12.6611.78%
2006A$11.334.38%
2005A$10.857.4%
2004A$10.1143.03%
2003A$7.0725.09%
2002A$5.6552.67%
2001A$3.7069.76%
2000A$2.18